January 1, 2021Open Access

Nanobody Conjugates for Targeted Cancer Therapy and Imaging

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

pharmacokinetics, and expand the range of potential applications. Herein, we review the superior characteristics of nanobodies in comparison to conventional antibodies and provide insight into recent developments in nanobody conjugates for targeted cancer therapy and imaging.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Kang et al. (Fri,) studied this question.

synapsesocial.com/papers/69ffd9ffef8139f8ff77753a https://doi.org/https://doi.org/10.1177/15330338211010117

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sequence and structure of V<sub>H</sub> domain from naturally occurring camel heavy chain immunoglobulins lacking light chains1994 · 479 citations
2Development of therapeutic antibodies for the treatment of diseases2020 · 2,136 citations
3Protein ligation: an enabling technology for the biophysical analysis of proteins2006 · 364 citations
418F-nanobody for PET imaging of HER2 overexpressing tumors2016 · 116 citations
5The Therapeutic Potential of Nanobodies2019 · 757 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo